STOCK TITAN
  1. Home
  2. RVMDW

Revolution Medicines Warrant (RVMDW) Stock Price, News & Analysis

RVMDW NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
108 252 sessions, October 28, 2025 to October 28, 2026
Largest daily move
+130.9% close of April 13, 2026
1-year change
+2253.4% closing prices, October 28, 2025 to October 28, 2026
1-month change
-14.9% closing prices, September 28, 2026 to October 28, 2026

Company Description

Revolution Medicines Warrant (NASDAQ: RVMDW) is classified in the biological products, (no diagnostic substances) industry.

RVMDW has gained 2253.4% over the past year. The last closing price was $9.55.

For FY2025, Revolution Medicines Warrant reported revenue of $0 with net income of -$1.1B and diluted earnings per share of -$5.95.

This page collects what Stock Titan holds for RVMDW, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

Chart
$9.55
+2.41%
+0.23
Last updated: October 28, 2026 at 15:59
+2253.4%
Performance 1 year
-
Market Cap
-
Shares outstanding

Revolution Medicines Warrant (RVMDW) closed at $9.55 on October 28, 2026. Over the past 12 months, the price has gained 2253.4%.

See what a $1,000 investment in RVMDW would be worth today

Average down calculator for RVMDW

RVMDW Metrics & Rankings

Revenue
$0.0
#3,650
Piotroski F-Score
1/9
#7,716
Month to date
-16.5%
View ranking
YTD
+916.1%
View ranking

Price returns through October 28, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All

No recent news available for RVMDW.

SEC Filings

View All

[4] Revolution Medicines (RVMD) officer exercised options at $33.62 and sold shares at $186.99.

[8-K] A $5M draw fee accompanies Revolution Medicines (RVMD)'s borrowing after FDA approval.

[4] Revolution Medicines (RVMD) officer exercises 6,000 options and sells 6,309 shares under a trading plan.

[4] Revolution Medicines (RVMD) counsel Jeff Cislini sold 765 shares at $207.3201 each under a trading plan.

[144] 6,000 shares from exercised options are listed for an officer’s proposed sale at Revolution Medicines (RVMD).

[4] At Revolution Medicines (RVMD), an officer exercised options at $33.62 before selling the shares at $200.54.

[4] Revolution Medicines (RVMD) director exercises options for 5,070 shares and sells 10,143 shares.

[144] After three earlier sales, an officer proposes selling 587 more Revolution Medicines (RVMD) shares.

[4] Revolution Medicines (RVMD) officer sells shares under preset trading plan

[144] Revolution Medicines (NASDAQ: RVMD) director plans stock sale from option exercise

Revolution Medicines Warrant has filed 10 recent SEC filings, including 6 Form 4, 3 Form 144, 1 Form 8-K. The most recent filing was submitted on October 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RVMDW SEC filings →

Financial Highlights

View Full Financials

operating income reached -$1.2B, and net income was -$1.1B. Diluted earnings per share stood at -$5.95. The company generated -$897.7M in operating cash flow. The current ratio was 7.14, measuring current assets divided by current liabilities.

$0
Revenue (FY2025)
-$1.1B
Net Income (FY2025)
-$5.95
Diluted EPS (FY2025)
-$897.7M
Operating Cash Flow
7.14
Current Ratio
-$1.2B
Operating Income

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Revolution Medicines Warrant (RVMDW) currently stands at 765 shares, up 8.8% from the previous reporting period. Since October 2025, short interest has decreased by 95.4%.

Days to Cover History

Last 12 Months

Days to cover for Revolution Medicines Warrant (RVMDW) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

RVMDW Company Profile & Sector Positioning

Revolution Medicines Warrant (RVMDW) and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Revolution Medicines Warrant (RVMDW)?

The current stock price of Revolution Medicines Warrant (RVMDW) is $9.55 as of October 28, 2026.

What is the revenue of Revolution Medicines Warrant (RVMDW) stock?

The FY2025 revenue of Revolution Medicines Warrant (RVMDW) is $0, from its most recent completed fiscal year.

What is the net income of Revolution Medicines Warrant (RVMDW)?

The FY2025 net income of Revolution Medicines Warrant (RVMDW) is -$1.1B, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Revolution Medicines Warrant (RVMDW)?

The diluted earnings per share (EPS) of Revolution Medicines Warrant (RVMDW) is -$5.95 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Revolution Medicines Warrant (RVMDW)?

The operating cash flow of Revolution Medicines Warrant (RVMDW) is -$897.7M for FY2025, its most recent completed fiscal year. Learn about cash flow.

What is the current ratio of Revolution Medicines Warrant (RVMDW)?

The current ratio of Revolution Medicines Warrant (RVMDW), current assets divided by current liabilities, was 7.14 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

What is the operating income of Revolution Medicines Warrant (RVMDW)?

The operating income of Revolution Medicines Warrant (RVMDW) is -$1.2B for FY2025, its most recent completed fiscal year. Learn about operating income.